Accès gratuit
Numéro
Med Sci (Paris)
Volume 17, Numéro 11, Novembre 2001
Page(s) 1112 - 1119
Section Articles de Synthèse
DOI http://dx.doi.org/10.1051/medsci/200117111112
Publié en ligne 15 novembre 2001
  1. Salfinger M. Characteristics of the various species of Mycobacteria. In : Rom WN, Garay SM, eds. Tuberculosis. New York : Little Brown and Company Inc, 1996 : 161–70.
  2. Wolinsky E. Mycobacteria. In : Davis BD, Dulbecco R, Eisen HN, Ginsberg HS, eds. Microbiology, 4th ed. Philadelphia : J.B. Lippincott Company, 1990 : 647–64.
  3. Calmette A.La vaccination préventive contre la tuberculose par le BCG. Paris : Masson, 1927.
  4. Holland SM. Nontuberculous mycobacteria. Am J Med Sci 2001; 321 : 49–55.
  5. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19 : 93–129.
  6. Stenger S, Modlin RL. T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol 1999; 2 : 89–93.
  7. Kobayashi K, Yoshida T. The immunopathogenesis of granulomatous inflammation induced by Mycobacterium tuberculosis. Meth Enzymol 1996; 9 : 204–14.
  8. Drobniewski F, Pozniak A, Uttley A. Tuberculosis and AIDS. J Med Microbiol 1995; 43 : 85–91.
  9. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol 1999; 118 (suppl 1) : 1–28.
  10. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection.Lancet 1995; 346 : 581.
  11. Casanova L, Blanche S, Emile JF, et al. Idiopathic disseminated bacillus Calmette-Guerin infection : a French national retrospective study. Pediatrics 1996; 98 : 774–8.
  12. Bach EA, Aguet M, Schreiber RD. The IFN gamma receptor : a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997; 15 : 563–91.
  13. Altare F, Jouanguy E, Lamhamedi-Cherradi S, et al. A causative relationship between mutant IFNγR1 alleles and impaired cellular response to IFN gamma in a compound heterozygous child. Am J Hum Genet 1998; 62 : 723–6.
  14. Holland SA, Dorman SE, Kwon A, et al . Abnormal regulation of interferon gamma, interleukin 12, and tumor necrosis factor alpha in interferon gamma receptor 1 deficiency. J Infect Dis 1998; 178 : 1095–104.
  15. Jouanguy E, Altare F, Lamhamedi S,et al .Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 1996; 335 : 1956–61.
  16. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335 : 1941–9.
  17. Pierre-Audigier C, Jouanguy E, Lamhamedi S, et al. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis 1997; 24 : 982–4.
  18. Roesler J, Kofink B, Wendisch J, et al. Recurrent mycobacterial and Listeria infections in a child with interferon γ receptor deficiency. Exp Hematol 1999; 27 : 1368–74.
  19. Jouanguy E, Dupuis S, Pallier A, et al. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma, J Clin Invest 2000; 105 : 1429–36.
  20. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998; 101 : 2364–9.
  21. Fieschi C, Dupuis S, Picard,C, Smith CI, Holland SM, Casanova JL. High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics 2001; 107 : E48.
  22. Jouanguy E, Lamhamedi-Cherradi S, Altare F, et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 1997; 100 : 2658–64.
  23. Allende LM, Lopez-Goyanes A, Paz-Artal E, et al. A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency. Clin Diagn Lab Immunol 2001; 8 : 133–7.
  24. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999; 21 : 370–8.
  25. Villella A, Picard C, Jouanguy E, et al. Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics 2001; 107 : E47.
  26. Doffinger R, Jouanguy E, Dupuis S, et al. Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection. J Infect Dis 2000; 181 : 379–84.
  27. Dupuis S, Dargemont C, Thomassin N, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001; 293 : 300–3.
  28. Dupuis S, Doffinger R, Picard C, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000; 178 : 129–37.
  29. Remus N, Reichenbach J, Picard C, et al. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res 2001; 50 : 8–13.
  30. Trinchieri G. Interleukin-12 : a cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70 : 83–243.
  31. Presky DH, Yang H, Minetti LJ, et al. A functional interleukin 12 receptor complex is composed of two beta- type cytokine receptor subunits. Proc Natl Acad Sci USA 1996; 93 : 14002–7.
  32. Zou J, Presky DH, Wu CY, Gubler U. Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta-1 and beta-2 and JAK kinases. J Biol Chem 1997; 272 : 6073–7.
  33. Jacobson NG, Szabo SJ, Weber-Nordt RM, et al. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 1995; 181 : 1755–62.
  34. Naeger LK, McKinney J, Salvekar A, Hoey,T. Identification of a STAT4 binding site in the interleukin-12 receptor required for signaling. J Biol Chem 1999; 274 : 1875–8.
  35. Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Buschenfelde KH, Neurath MF. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol 1998; 160 : 3642–7.
  36. Altare F, Lammas D, Revy P, et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin infection. J Clin Invest 1998; 102 : 2035–40.
  37. Aksu G, Trpan C, Çavuolu C, Soydan S, Altare F, Casanova JL, Kutukculer N. Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta-1 deficiency. Pediatr Infect Dis J 2001; 20 : 551–3.
  38. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280 : 1432–5.
  39. De Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998; 280: 1435–8.
  40. Sakai T, Matsuoka M, Aoki M, Nosaka K, Mitsuya H. Missense mutation of the interleukin-12 receptor beta-1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. Blood 2001; 97 : 2688–94.
  41. Altare F, Ensser A, Breiman A, et al. Interleukin-12 receptor β1-deficiency in a patient with abdominal tuberculosis. J Infect Dis 2001; 184 : 231–6.
  42. Altare F, Jouanguy E, Lamhamedi S, Döffinger R, Fischer A, Casanova JL. Mendelian susceptibility to mycobacterial infections in man. Curr Opin Immunol 1998; 10 : 413–7.
  43. Horvath KD, Whelan RL. Intestinal tuberculosis : return of an old disease. Am J Gastroenterol 1998; 93 : 692–6.
  44. Verhagen CE, de Boer T, Smits HH, et al. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta-1 (IL-12R beta-1). Evidence for an IL-12R beta-1-independent pathway of IL-12 responsiveness in human T cells. J Exp Med 2000; 192 : 517–28.
  45. Zhang M, Gately MK, Wang E, et al. Interleukin 12 at the site of disease in tuberculosis, J Clin Invest 1994; 93 : 1733–9.
  46. Zhang M, Gong J, Presky DH, Xue W, Barnes PF. Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J Immunol 1999; 162 : 2441–7.
  47. Flesch IE, Hess JH, Huang S, et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med 1995; 181 : 1615–21.
  48. DiTirro J, Rhoades ER, Roberts AD, et al. Disruption of the cellular inflammatory response to Listeria monocytogenes infection in mice with disruptions in targeted genes. Infect Immun 1998; 66 : 2284–9.
  49. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M. Consensus statement. Global burden of tuberculosis : estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282 : 677–86.
  50. Abel L, Casanova JL, Genetic predisposition to clinical tuberculosis : bridging the gap between simple and complex inheritance. Am J Hum Genet 2000; 67 : 274–7.